BHVN — BIOHAVEN PHARMACEUTICAL HOLD

Ownership history in Quantbot Technologies LP  ·  10 quarters on record

This page tracks every 13F SEC filing in which Quantbot Technologies LP reported a position in BIOHAVEN PHARMACEUTICAL HOLD (BHVN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2020 Q4)
Avg. % of fund
0.01%
First filed
2018 Q2
Last filed
2025 Q3
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 6,455 -2,385 -27.0% 0.00% $97K $15.01
2025 Q2 ADDED 8,840 +8,102 +1097.8% 0.00% $125K $14.11
2025 Q1 REDUCED 738 -8,770 -92.2% 0.00% $18K $24.04
2024 Q4 ADDED 9,508 +9,498 +94980.0% 0.01% $355K $37.35
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    BHVN price (monthly, adj. close)

Other funds also holding BHVN

As of 2025 Q4 — sorted by position size

Knoll Capital Management, LLC 3Y 7Y 12.06% ORACLE INVESTMENT MANAGEMENT INC 3Y 7Y 5.19% Lion Point Capital, LP 3Y 7Y 3.02% MYDA Advisors LLC 3Y 7Y 2.69% 5AM Venture Management, LLC 3Y 2.62% Sarissa Capital Management LP 3Y 7Y 2.6% DAFNA Capital Management LLC 3Y 7Y 2.51% PFIZER INC 2.41% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.38% Sio Capital Management, LLC 3Y 7Y 2.21%
← Back to Quantbot Technologies LP Holdings